Rainbow Child.

Why is Rainbow Childrens Medicare Ltd falling/rising?

As of 02-Sep, the stock price of Rainbow Childrens Medicare Ltd is currently at 1,430.80, reflecting a decline of 0.81%. Despite some positive indicators like increased investor participation and strong management efficiency, the stock has underperformed against benchmarks and moving averages, indicating a negative trend.

As of 02-Sep, the stock price of Rainbow Childrens Medicare Ltd is falling, currently at 1,430.80, reflecting a decrease of 11.7 points or 0.81%. This decline can be attributed to its recent performance metrics, which indicate a negative trend over various periods. For instance, the stock has underperformed the benchmark Sensex over the past week and month, with declines of 1.22% and 5.97%, respectively, compared to the Sensex's losses of 1.17% and 1.95%. <BR><BR>Additionally, the stock's performance today has underperformed its sector by 0.35%. Although the stock is trading higher than its 100-day and 200-day moving averages, it is lower than its 5-day, 20-day, and 50-day moving averages, suggesting a short-term weakness. <BR><BR>Despite these negative indicators, there are some positive aspects, such as rising investor participation, with delivery volume increasing by 129.12% against the 5-day average, and strong management efficiency reflected in a high Return on Capital Employed (ROCE) of 19.70%. However, these positives have not been sufficient to counteract the overall downward movement in the stock price.

Which are the latest news on Rainbow Child.?

Who are in the management team of Rainbow Child.?

The management team of Rainbow Child includes Ramesh Kancharla (Chairman & Managing Director), Dinesh Kumar Chirla (Whole-time Director), and five Independent Directors: Aluri Rao Srinivasa, Anil Dhawan, Sundari Raviprasad Pisupati, Santanu Mukherjee, along with Ashish Kapil as Company Secretary & Compliance Officer.

The management team of Rainbow Child consists of the following individuals:<BR><BR>1. **Ramesh Kancharla** - Chairman & Managing Director<BR>2. **Dinesh Kumar Chirla** - Whole-time Director<BR>3. **Aluri Rao Srinivasa** - Independent Director<BR>4. **Anil Dhawan** - Independent Director<BR>5. **Sundari Raviprasad Pisupati** - Independent Director<BR>6. **Santanu Mukherjee** - Independent Director<BR>7. **Ashish Kapil** - Company Secretary & Compliance Officer<BR><BR>If you need more details about their roles or contributions, feel free to ask!

What does Rainbow Child. do?

Rainbow Childrens Medicare Ltd is a small-cap company in the hospital industry, reporting net sales of 470 Cr and a net profit of 61 Cr for June 2026. It has a market cap of INR 14,516 Cr, a P/E ratio of 50, and a dividend yield of 0.24%.

Overview:<BR>Rainbow Childrens Medicare Ltd operates in the hospital industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated as Rainbow Children's Medicare Private Limited in 1998 and later converted to a public limited company, changing its name to Rainbow Children's Medicare Limited on November 20, 2021. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 470 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 61 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 14,516 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 50.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.24% <BR>Debt Equity: 0.27 <BR>Return on Equity: 16.97% <BR>Price to Book: 8.90 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Rainbow Child.?

Rainbow Child's peers include Aster DM Quality, Global Health, Narayana Hrudaya, and others, with varying management risks and growth rates. Aster DM Quality leads in 1-year returns at 25.77%, while Rainbow Child has the lowest at -5.86%.

Peers: The peers of Rainbow Child are Aster DM Quality, Global Health, Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, Health.Global, Jupiter Life Lin, Yatharth Hospit., and Kovai Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Global Health, Narayana Hrudaya, and Jupiter Life Lin, while Good management risk is found at Aster DM Quality, Krishna Institu., Dr Agarwal's Hea, Rainbow Child., and Kovai Medical. Average management risk is present at Health.Global, while Below Average management risk is noted at Yatharth Hospit. Growth is Excellent at Narayana Hrudaya, Average at Global Health, Dr Agarwal's Hea, and Yatharth Hospit., and Below Average at Aster DM Quality, Krishna Institu., Rainbow Child., Jupiter Life Lin, and Kovai Medical. Capital Structure is Excellent at Global Health and Jupiter Life Lin, Good at Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, Rainbow Child., and Kovai Medical, Average at Aster DM Quality and Health.Global, and Below Average at Yatharth Hospit.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aster DM Quality at 25.77%, while the lowest is Rainbow Child at -5.86%. Rainbow Child's return is significantly lower than the highest peer. Additionally, the peers with negative six-month returns are Narayana Hrudaya and Krishna Institu.

How big is Rainbow Child.?

As of 31st August, Rainbow Childrens Medicare Ltd has a market capitalization of 14,516.00 Cr, with recent Net Sales of 1,820.14 Cr and a Net Profit of 285.39 Cr.

As of 31st August, Rainbow Childrens Medicare Ltd has a market capitalization of 14,516.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 1,820.14 Cr and a Net Profit of 285.39 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, with Shareholder's Funds amounting to 1,648.07 Cr and Total Assets of 2,724.77 Cr.

Are Rainbow Childrens Medicare Ltd latest results good or bad?

Rainbow Children's Medicare Ltd reported record revenue growth of 33.17% to ₹469.99 crores, but net profit declined by 21.38% to ₹60.57 crores, with operating margins contracting to 28.65%. While revenue growth is positive, the drop in profit and margins indicates challenges in maintaining profitability during expansion.

Rainbow Children's Medicare Ltd's latest results present a mixed picture. On one hand, the company achieved a record revenue of ₹469.99 crores for the quarter, reflecting a strong year-on-year growth of 33.17%. This indicates robust demand and operational momentum, particularly in the specialized paediatric healthcare sector.<BR><BR>However, the downside is notable. The net profit for the quarter declined by 21.38% compared to the previous quarter, totaling ₹60.57 crores. This decline in profitability raises concerns, especially as operating margins contracted significantly to 28.65% from 31.46% in the prior quarter. The margin compression is attributed to rising operational costs linked to aggressive capacity expansion and increased employee expenses.<BR><BR>Overall, while the revenue growth is a positive sign, the substantial drop in profit and operating margins suggests that the company is facing challenges in maintaining profitability amidst its expansion efforts. Investors should monitor how the company addresses these margin pressures in the upcoming quarters.

Should I buy, sell or hold Rainbow Childrens Medicare Ltd?

When is the next results date for Rainbow Childrens Medicare Ltd?

The next results date for Rainbow Childrens Medicare Ltd is July 30, 2026.

The next results date for Rainbow Childrens Medicare Ltd is scheduled for July 30, 2026.

Is Rainbow Child. technically bullish or bearish?

As of December 1, 2025, the technical trend is mildly bearish, influenced by bearish indicators from the weekly MACD and moving averages, despite some bullish momentum in the weekly RSI and mixed monthly signals.

As of 1 December 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD and Bollinger Bands indicating bearish conditions, while the daily moving averages also reflect a bearish outlook. The weekly RSI shows bullish momentum, but the overall monthly indicators remain mixed, with the KST showing bullish on a monthly basis. Dow Theory suggests a mildly bullish stance on the weekly timeframe, but with no clear trend on the monthly. The stock's recent performance against the Sensex has been negative across multiple time frames, further supporting the bearish sentiment.

How has been the historical performance of Rainbow Child.?

Rainbow Child has shown consistent growth over the past six years, with net sales increasing from 650.05 Cr in Mar'21 to 1,515.87 Cr in Mar'25, and profit after tax rising from 39.57 Cr to 244.23 Cr. The company has eliminated long-term debt and improved cash flow, indicating strong financial health.

Answer:<BR>The historical performance of Rainbow Child shows a consistent growth trend across various financial metrics over the past six years.<BR><BR>Breakdown:<BR>Rainbow Child's net sales have increased significantly from 650.05 Cr in Mar'21 to 1,515.87 Cr in Mar'25, reflecting a strong upward trajectory. Total operating income followed a similar trend, rising from 719.39 Cr in Mar'20 to 1,515.87 Cr in Mar'25. The company's operating profit (PBDIT) also saw substantial growth, climbing from 173.10 Cr in Mar'21 to 540.90 Cr in Mar'25, although the operating profit margin slightly decreased from 33.07% in Mar'24 to 32.32% in Mar'25. Profit before tax rose from 55.70 Cr in Mar'21 to 330.00 Cr in Mar'25, while profit after tax increased from 39.57 Cr in Mar'21 to 244.23 Cr in Mar'25, showcasing improved profitability. The total assets of the company grew from 1,018.89 Cr in Mar'20 to 2,347.40 Cr in Mar'25, indicating a solid expansion in the asset base. Furthermore, the company has eliminated long-term borrowings, achieving a total debt of 0.00 Cr in Mar'25, which reflects a strong financial position. Cash flow from operating activities has also improved, rising from 142.00 Cr in Mar'21 to 395.00 Cr in Mar'25, contributing to a net cash inflow of 10.00 Cr in Mar'25. Overall, Rainbow Child has demonstrated robust growth and financial health over the years.

Who are the top shareholders of the Rainbow Child.?

The top shareholders of Rainbow Child include Ramesh Kancharla with 31.04%, 23 mutual funds holding 11.47%, and 188 foreign institutional investors with 23.69%. The highest public shareholder is the DSP Aggressive Hybrid Fund at 4.27%, while individual investors own 10.34% of the shares.

The top shareholders of Rainbow Child include the promoters, with Ramesh Kancharla holding the highest individual stake at 31.04%. Additionally, the company has significant institutional investment, with 23 mutual funds collectively holding 11.47% and 188 foreign institutional investors (FIIs) holding 23.69%. The highest public shareholder is the DSP Aggressive Hybrid Fund, which holds 4.27%. Individual investors also have a notable presence, owning 10.34% of the shares.

Is Rainbow Child. overvalued or undervalued?

As of June 12, 2023, Rainbow Child is considered very expensive and overvalued with a PE ratio of 58.94, a Price to Book Value of 9.77, and an EV to EBITDA ratio of 29.64, despite a strong three-year stock performance of 199.47%.

As of 12 June 2023, the valuation grade for Rainbow Child. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued, with a PE ratio of 58.94, a Price to Book Value of 9.77, and an EV to EBITDA ratio of 29.64. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Rainbow Child. has a higher PE ratio than Max Healthcare Institute Ltd. at 100.29 and Apollo Hospitals Enterprise Ltd. at 69.03, both of which are also categorized as very expensive. The PEG ratio of 4.86 further underscores the overvaluation, especially when compared to peers like Narayana Hrudayalaya Ltd. with a PEG of 37.59. Despite a strong stock performance over the past three years, with a return of 199.47%, the current valuation metrics indicate that Rainbow Child. is not justified at its current price of 1408.40.

Has Rainbow Child. declared dividend?

Rainbow Childrens Medicare Ltd has declared a 30% dividend, amounting to 3 per share, with an ex-date of June 27, 2025. The dividend yield is 0.21%, and total returns have varied across periods, showing significant growth over the long term despite short-term declines.

Rainbow Childrens Medicare Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 27 Jun 25<BR><BR>Dividend Yield: 0.21%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -14.08%, the dividend return was 0.18%, resulting in a total return of -13.9%.<BR><BR>Over the past year, the price return was 8.36%, the dividend return was 0.46%, leading to a total return of 8.82%.<BR><BR>In the 2-year period, the price return was 52.26%, the dividend return was 0.94%, culminating in a total return of 53.2%.<BR><BR>For the 3-year period, the price return was 196.48%, the dividend return was 2.53%, resulting in a total return of 199.01%.<BR><BR>In the 4-year period, there was no price return, no dividend return, and a total return of 0.0%.<BR><BR>Similarly, in the 5-year period, there was no price return, no dividend return, and a total return of 0.0%.<BR><BR>Overall, Rainbow Childrens Medicare Ltd has declared a dividend and has shown varying total returns across different periods, with significant growth in the longer terms despite some negative performance in the short term. The dividend yield indicates a modest return relative to the share price.